<!DOCTYPE html>
<html>
<head>
	<title>Genomics England - Rare Diseases - Familial colon cancer</title>
	<meta charset="utf-8"/>
	<script type="text/javascript" src="inc/jquery.min.js"></script>
	<link rel="stylesheet" type="text/css" href="inc/style.css" />
	<!-- <script src="../file/js/modernizr.js"></script>  -->
</head>
<body>
	<div class="container">
		<h1>Familial colon cancer</h1>
		<div id="nav">
			<br /><br /><a href="index.html" style="margin-left:20px;">&#171; Back to homepage</a>
		</div>
		<div class="main">
			<ul class="tabs">
				<li>
					<input type="radio" checked name="tabs" id="tab1">
					<label for="tab1">Eligibility</label>
					<div id="tab-content1" class="tab-content animated fadeIn">
            
  <p class="preserve-new-lines"></p>

  <h3>Inclusion Criteria</h3>
  <p class="preserve-new-lines">PREFERABLY:
proband is affected by colorectal cancer (age &lt;50)  
Additional 3 family members (FDR, SDR, TDR) affected by colorectal cancer  (average age &lt;60)
Samples to be supplied from proband AND &gt;=2 affected relatives

OR

proband is affected by colorectal or Lynch-related cancer (age &lt;50)  
Additional 2 family members (FDR or SDR of each other) affected by colorectal or Lynch-related cancer  (average age &lt;60).
If proband’s tumour is colorectal cancer, the tumour must exhibit microsatellite instability.
Cancer diagnosis confirmed in  &gt;= 2 family members 
Proband has &lt;=1 living affected family members (ie ineligible for multiplex CRC)
Samples to be supplied from: proband only

(Lynch-related tumours: 
Colorectal cancer
Endometrial cancer
Ovarian cancer
Pancreatic cancer
Ureter cancer
Benign skin tumours
Sebaceous adenoma
Sebaceous epithilioma
Keratoacanthoma
Skin cancers
Sebaceous carcinoma
Transitional cell cancer of renal pelvis
Gastric cancer
Hepatobiliary tract cancer
Small bowel cancer
Glioblastoma)

Unaffected individuals should not be recruited in this disorder. These singleton recruits will not contribute to the overall singleton monitoring metrics applied to GMCs.</p>

  <h3>Exclusion Criteria</h3>
  <p class="preserve-new-lines"></p>

  <h3>Prior Genetic Testing</h3>
  <p class="preserve-new-lines">- Results should have been reviewed for all genetic tests undertaken, including disease-relevant genes in exome sequencing data. The patient is not eligible if they have a molecular diagnosis for their condition. 
- Genetic testing should continue according to routine local practice for this phenotype regardless of recruitment to the project; results of these tests must be submitted via the ‘Genetic investigations’ section of the data capture tool to allow comparison of WGS with current standard testing.  

PLEASE NOTE: The sensitivity of WGS compared to current diagnostic genetic testing has not yet been established. It is therefore important that tests which are clinically indicated under local standard practice continue to be carried out.</p>

  <h3>Genes</h3>
  <p class="preserve-new-lines">Testing as below is strongly recommended PRIOR TO RECRUITMENT to allow appropriate management of families with readily detectable mutations in known disease genes:  
MULTIPLEX FAMILY RECRUITED - GENES TO BE EXCLUDED ON PRIOR TESTING:  
- MLH1, MSH2, MSH6
 AND 
- +PMS2 (if IHC shows isolated loss of PMS2)  
LYNCH SYNDROME TESTING ONLY REQUIRED IF TUMOURS IN THE FAMILY SHOW MICROSATELLITE INSTABILITY, 
AND 
- +APC (if proband has &gt;10 adenomatous polyps)  

PROBAND-ONLY RECRUITMENT – GENES TO BE EXCLUDED ON PRIOR TESTING: 
- MLH1, MSH2, MSH6 AND 
- +PMS2 (if IHC shows isolated loss of PMS2) AND 
- +APC (if proband has &gt;10 adenomatous polyps)</p>

  <h3>Closing Statement</h3>
  <p class="preserve-new-lines">These requirements will be kept under continual review during the main programme and may be subject to change.</p>


					</div>
				</li>
				<li>
					<input type="radio" name="tabs" id="tab2">
					<label for="tab2">Phenotypes</label>
					<div id="tab-content2" class="tab-content animated fadeIn">
            
  <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0003003" onclick="window.open(this.href);return false;">Colon cancer</a></h3>
    <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0030255" onclick="window.open(this.href);return false;">Large intestinal polyposis</a></h3>
    <p class="preserve-new-lines">The presence of multiple polyps in the large intestine.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0030256" onclick="window.open(this.href);return false;">Small intestinal polyposis</a></h3>
    <p class="preserve-new-lines">The presence of multiple polyps in the small intestine.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0004394" onclick="window.open(this.href);return false;">Multiple gastric polyps</a></h3>
    <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0012114" onclick="window.open(this.href);return false;">Endometrial carcinoma</a></h3>
    <p class="preserve-new-lines">A carcinoma of the endometrium, the mucous lining of the uterus.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0100615" onclick="window.open(this.href);return false;">Ovarian neoplasm</a></h3>
    <p class="preserve-new-lines">A tumor (abnormal growth of tissue) of the ovary.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0006725" onclick="window.open(this.href);return false;">Pancreatic adenocarcinoma</a></h3>
    <p class="preserve-new-lines">The presence of an adenocarcinoma of the pancreas.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0100516" onclick="window.open(this.href);return false;">Neoplasm of the ureter</a></h3>
    <p class="preserve-new-lines">The presence of a neoplasm of the ureter.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0008069" onclick="window.open(this.href);return false;">Neoplasm of the skin</a></h3>
    <p class="preserve-new-lines">A tumor (abnormal growth of tissue) of the skin.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0012126" onclick="window.open(this.href);return false;">Stomach cancer</a></h3>
    <p class="preserve-new-lines">A cancer arising in any part of the stomach.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0100574" onclick="window.open(this.href);return false;">Biliary tract neoplasm</a></h3>
    <p class="preserve-new-lines">A tumor (abnormal growth of tissue) of the biliary system.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0100833" onclick="window.open(this.href);return false;">Neoplasm of the small intestine</a></h3>
    <p class="preserve-new-lines">The presence of a neoplasm of the small intestine.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0100843" onclick="window.open(this.href);return false;">Glioblastoma</a></h3>
    <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0100246" onclick="window.open(this.href);return false;">Osteoma</a></h3>
    <p class="preserve-new-lines">Osteomas are bony growths found most commonly on the skull and mandible; however, they may occur in any bone of the body. Osteomas do not usually cause clinical problems and do not become malignant.</p>
  


					</div>
				</li>
				<li>
					<input type="radio" name="tabs" id="tab3">
					<label for="tab3">Clinical Tests</label>
					<div id="tab-content3" class="tab-content animated fadeIn">
            
  Clinical tests are not available


					</div>
				</li>
			</ul>
		</div>
	</div>
</body>
</html>
